Bibliographic citations
Quispe, L., (2018). Esquizofrenia como factor de riesgo para dislipidemias en pacientes del Hospital Regional Docente de Trujillo [Tesis, Universidad Privada Antenor Orrego - UPAO]. https://hdl.handle.net/20.500.12759/4279
Quispe, L., Esquizofrenia como factor de riesgo para dislipidemias en pacientes del Hospital Regional Docente de Trujillo [Tesis]. : Universidad Privada Antenor Orrego - UPAO; 2018. https://hdl.handle.net/20.500.12759/4279
@misc{renati/376907,
title = "Esquizofrenia como factor de riesgo para dislipidemias en pacientes del Hospital Regional Docente de Trujillo",
author = "Quispe Huaman, Liz Karen",
publisher = "Universidad Privada Antenor Orrego - UPAO",
year = "2018"
}
Objective: To demonstrate if schizophrenia is a risk factor for dyslipidemias in patients older than 15 years of the Regional Teaching Hospital of Trujillo in the period January 2013 - December 2017. Material and Methods: A study was conducted in the HRDT of observational, analytical, retrospective, cohort design in the period January 20013 - December 2017. Including a total of 159 patients who were divided into 2 groups: 53 with schizophrenia (exposed) and 106 without schizophrenia (not exposed), the association was found using the Relative Risk Association and Fisher's Exact Test was used to find the statistical significance with p <0.05. Results: The mean ages of the patients with and without dyslipidemias were 37.3 + - (8.47) years and 43.8 + - (9.17) years respectively, finding a significant difference with a p = 0.001. Regarding the group of patients with dyslipidemias, 73% were found in the male gender and 27% in the female gender, and 41% in the male gender and 59% in the female group without dyslipidemia. Likewise, in obesity and diabetes mellitus it was significantly higher in the group of patients with dyslipidemias than in the group of patients without dyslipidemias and in hypertension the frequency was higher in the group of patients without dyslipidemia than in the group of patients with dyslipidemias. Likewise, obesity, diabetes mellitus and hypertension were associated with dyslipidemias with p <0.05. No significant differences were observed in relation to the variables time of illness, origin and anemia between the study groups (Table 1). In patients with schizophrenia the frequency of dyslipidemia was 38% and in patients without schizophrenia it was 9%. When comparing the average of the dyslipidemia frequencies, a significant difference was found, with a RR = 4, 95% CI 2.02 to 7.93, p = 0.001 (Table 2). Conclusion: The presence of schizophrenia is a risk factor for dyslipidemias in patients older than 15 years of the Regional Teaching Hospital of Trujillo.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.